CClinicalTrials.gg
Status unknownNCT02801149SMRIUpdated Aug 8, 2017

The Use of MRI in the Assessment of Suspected Scaphoid Fracture With Negative Findings on the Initial Plain Radiography

An interventional study of Wrist Magnetic Resonance Imaging (MRI) in Scaphoid Fracture, sponsored by Guy's and St Thomas' NHS Foundation Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2017-08-08.

Sponsored by Guy's and St Thomas' NHS Foundation Trust · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Given that: 1) various clinical complications may arise from a misdiagnosed scaphoid fracture; and 2) clinical and radiographic diagnosis of scaphoid fracture is often challenging, particularly at the time of presentation, this study aims to evaluate whether the use of Magnetic Resonance Imaging (MRI) in the investigation of patients presenting with a suspected scaphoid fracture, with negative findings from the initial conventional radiography (4-view plain x-ray), leads to improved levels of efficiency, quality of care and patient experience.

This study is a single centre randomised, non-blinded, prospective study. Participants will be randomised, following the initial negative conventional radiography, to either: no further imaging at A\&E (consistent with current clinical practice); or 2) wrist MRI. The study considers a follow-up period of 6 months.

Read the detailed description

The scaphoid bone is an obliquely orientated bone on the radial (thumb) side of the wrist, between the distal carpal row and the radius. Wrist injury is a common presentation to the Emergency Department (ED) in the UK. Amongst these patients, the scaphoid is the most commonly fractured carpal bone, accounting for 51-90% of carpal fractures and between 2-7% of all fractures.

Given that: 1) various clinical complications may arise from a misdiagnosed scaphoid fracture; and 2) clinical and radiographic diagnosis of scaphoid fracture is often challenging, particularly at the time of presentation, this study aims to evaluate whether the use of Magnetic Resonance Imaging (MRI) in the investigation of patients presenting with a suspected scaphoid fracture, with negative findings from the initial conventional radiography (4-view plain x-ray), leads to improved levels of efficiency, quality of care and patient experience.

This study is a single centre randomised, non-blinded, prospective study. Participants will be randomised, following the initial negative conventional radiography, to either: no further imaging at A\&E (consistent with current clinical practice); or 2) wrist MRI. The study considers a follow-up period of 6 months.

02

Conditions studied

  • Scaphoid Fracture

Browse trials for

03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's planned enrollment of 136 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Guy's and St Thomas' NHS Foundation Trust is the lead sponsor of 284 studies on the registry; 79 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Every patient aged 16 years or over presenting at A\&E/UCC with clinical history and examination consistent with a suspected scaphoid fracture but negative findings on the initial 4-view plain x-ray. It is considered that a patient has suspected scaphoid fracture if at least one of the following criteria are present:

  • Isolated pain / tenderness over the Anatomical Snuff Box (ASB) or Scaphoid Tubercle or pain in the scaphoid region during axial loading of the 1st metacarpal.
  • History of recent fall (\< 14 days) on an out-stretched hand (FOOSH), wrist injury or poor history associated with examination findings suggestive of scaphoid fracture.

Furthermore, only patients that present at A\&E/UCC during the following schedule of MRI normal working hours will be included in the study:

  • Patients screened for the study at A\&E/UCC on weekdays after 7.30 am and before 6 pm;
  • Patients screened for the study at A\&E/UCC on weekends or Bank Holidays after 9 am and before 4 pm.

Exclusion criteria

Exclusion Criteria:

  • Patients presenting outside GSTT's catchment area who are not willing to be followed-up at GSTT;
  • Patients with a confirmed scaphoid fracture following the initial 4-view plain x-ray;
  • Patients with confirmed ipsilateral upper limb injury/injuries (e.g. wrist/forearm/arm injury) following initial conventional x-ray examination(s) - regardless of the findings around the suspected scaphoid fracture.
  • Patients with suspected scaphoid fracture not admitted through A\&E at St Thomas' Hospital or Urgent Care Centre (UCC) at Guy's Hospital;
  • Patients who lack capacity to give consent or participate in the study;
  • Patients that are already taking part in a Clinical Trial of an Investigational Medicinal Product (CTIMP);
  • Prisoners.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
136 participants (estimated)

Study arms

  • No intervention
    No further imaging

    Patients randomised to this group will receive standard care, i.e. will not undergo additional imaging scans at A\&E/Urgent Care Centre.

  • Experimental
    Wrist Magnetic Resonance Imaging (MRI)

    Patients randomised to this group will undergo an additional 3-sequence wrist MRI during the initial A\&E/Urgent Care Centre episode.

    Procedure: Wrist Magnetic Resonance Imaging (MRI)

Interventions

  • ProcedureWrist Magnetic Resonance Imaging (MRI)

    Patients that enter this group are randomised to receive non-standard care with a 3-sequence MRI scan of the scaphoid following the initial conventional radiography.

06

What researchers measure

Primary outcomes

  1. 3-month costs (measured in £ per patient) associated with the two clinical groups following the A&E/UCC initial episode

    The primary objective is to estimate the 3-month costs associated with two clinical pathways at A\&E/UCC: (i) the current pathway, with x-ray as the only imaging modality (no further imaging group); or (ii) the proposed pathway (MRI group), with a hybrid approach i.e. using x-ray as the initial imaging modality and subsequently MRI for patients with negative findings on the initial x-ray.

    Time frame: 3 months

Secondary outcomes

  1. 6-month costs (measured in £ per patient) associated with the two clinical groups following the A&E/UCC initial episode

    This objective aims to estimate the 6-month costs associated with two clinical pathways at A\&E/UCC: (i) the current pathway, with x-ray as the only imaging modality (no further imaging group); or (ii) the proposed pathway (MRI group), with a hybrid approach i.e. using x-ray as the initial imaging modality and subsequently MRI for patients with negative findings on the initial x-ray.

    Time frame: 6 months

  2. 3-month cost-effectiveness analysis (ICER measured as £ per QALY) following the A&E/UCC initial episode

    A cost-effectiveness analysis takes into account both the costs and outcomes related to the interventions. An unique incremental cost-effectiveness ratio (ICER), measured as £ per QALY, will be estimated comparing both interventions at 3 months.

    Time frame: 3 months

  3. 6-month cost-effectiveness analysis (ICER measured as £ per QALY) following the A&E/UCC initial episode

    A cost-effectiveness analysis takes into account both the costs and outcomes related to the interventions. An unique incremental cost-effectiveness ratio (ICER), measured as £ per QALY, will be estimated comparing both interventions at 6 months.

    Time frame: 6 months

  4. Cost per correctly diagnosed scaphoid fracture (measured in £ per correct diagnosis)

    The cost per correctly diagnosed scaphoid fracture with the proposed intervention compared to standard care will be considered to evaluate whether overall potential cost-savings are aligned with the benefits of an improved diagnostic pathway. Findings from the treatment group (with MRI) and the control group (no further imaging) will be compared against the 3-month 4-view plain x-ray (gold standard). If both imaging findings are consistent, it is considered that a correct diagnosis was achieved.

    Time frame: 3 months

  5. Patient satisfaction in both groups (to be assessed using non-standard questionnaires, based on a 1-5 likert scale)

    Patient experience will be evaluated using patient questionnaires. The underlying hypothesis is that the use of MRI will promote an improvement in the patient's overall experience, due to: i) a decrease in the need for secondary care contacts; ii) the reduction of plaster casts utilisation; and (iii) an improved and definitive diagnosis and subsequent treatment.

    Time frame: 3 months

  6. Likelihood ratio of the proposed pathway (i.e. wrist MRI group) in the detection of scaphoid fracture compared to the current pathway (no further imaging group)

    The overall likelihood ratio and diagnostic accuracy (sensitivity and specificity) of the MRI for the early identification of scaphoid fractures in the proposed pathway will be assessed against a 3-month conventional 4-view plain x-ray as the comparator.

    Time frame: 3 months

  7. Time (measured in days) taken to reach a definitive diagnosis and the first major treatment decision based on the MRI in comparison to the current pathway

    The study will evaluate the time required to achieve a definitive diagnosis and deliver the subsequent appropriate treatment. It is considered that a definitive diagnosis is reached once there is agreement between the initial (at A\&E/UCC) and/or the follow-up (at fracture clinic) imaging exams and the final 3-month plain x-ray.

    Time frame: 3 months

  8. Percentage of agreement between radiographers and radiologists in the diagnosis of suspected scaphoid fractures

    The percentage of agreement between radiographers and radiologists in the diagnosis of suspected scaphoid fractures (i.e. rule in/rule out) using MRI datasets will also be assessed. This information will provide pivotal insight as to how the proposed clinical pathway can operationally be rolled out, as well as future areas of research.

    Time frame: 1 week

  9. Time off work or informal care needs (measured in days) due to the suspected scaphoid fracture.

    The study aims to assess potential benefits from a broader societal perspective. For this purpose, time off work and informal care required due to the suspected scaphoid fracture will be recorded. The underlying hypothesis is that the use of MRI might reduce the amount of unnecessary plaster casts (i.e. in patients with no scaphoid fracture) and translate into a reduction in days off work and subsequent need for informal care.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Guy's and St Thomas' NHS Foundation Trust
    London, United Kingdom
    • Bharti Malhotra · Contact
    • Tiago Rua · Contact
    Recruiting
08

References and documents

Publications

  • Rua T, Vijayanathan S, Parkin D, Goh V, McCrone P, Gidwani S. Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture. Clin Trials. 2018 Apr;15(2):120-129. doi: 10.1177/1740774517748320. Epub 2018 Jan 24. PubMed 29366329 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02801149
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborators
King's College London
Responsible party
Sponsor
First posted
Jun 15, 2016
Start date
Jun 6, 2016
Primary completion
Apr 2018 (estimated)
Completion
Jul 2018 (estimated)
Last update
Aug 8, 2017

Study contacts

Bharti Malhotra, MSc
Contact
bharti.malhotra@kcl.ac.uk
Tiago Rua, MSc
Contact
tiago.rua@kcl.ac.uk
Sam Gidwani
principal investigator · Guy's and St Thomas' NHS Foundation Trust

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion